vimarsana.com

Page 190 - ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Corbin Clinical Resources, Inc Welcomes New Executive Team

Ken Knudson joins Corbin Clinical Resources, Inc. as new CEO. Photo courtesy of Vibrant Image. Rich Tourtellot (left) and David Tanksley (right) join as new Senior Vice Presidents of Sales. Photo courtesy of Vibrant Image. Corbin Clinical Resources is expanding its commercial organization with the hiring of Ken Knudson, as CEO, as well as David Tanksley and Rich Tourtellot as Senior Vice Presidents of Sales. Their expertise in the field of urology will greatly enhance Corbin s ability to deliver precision and safety to patient care. Ken Knudson has spent the past two years at Boston Scientific (BSC) after the successful acquisition of Augmenix Inc. in 2018 for six hundred million dollars, where he and his team were able to double sales year after year. Ken was instrumental in leading the commercial development and expansion as the Executive Vice President of Global Sales and Marketing for six years. He started his medical device career at BSC in 1995 and held several senior manage

Immunologix Laboratories Expands Translational Sciences Team

Immunologix Laboratories Expands Translational Sciences Team News provided by Share this article Share this article TAMPA, Fla., Feb. 16, 2021 /PRNewswire/ Immunologix Laboratories announces two additions to the Translational Sciences division with Corinna Fiorotti, Ph.D. as Executive Director, Translational Sciences and Safa Alvandkouhi as Director, Business Operations. The continued growth of Translational Sciences highlights Immunologix Laboratories commitment to building an unparalleled model of scientific partnership with our clients. (PRNewsfoto/Immunologix Laboratories) We are excited about expanding our Translational Sciences team with the addition of Dr. Fiorotti as an Executive Director. Dr. Fiorotti brings extensive bioanalytical experience in both traditional and emergent therapeutic modalities, including monoclonal antibodies, bispecific and multi-domain therapeutics, antibody-drug conjugates and cell and gene therapies. Our clients are already benefiting from

The Philippines Unveils Unique Advantages in Covid-critical PPE and Medical Supplies Manufacturing at Japanese Business Event

Share this article Share this article COST EFFICIENT, RESILIENT TALENT POOL AND STRATEGIC POLICY REFORMS PROVIDE INVESTMENT OPPORTUNITIES FOR JAPAN AND NEIGHOURING MARKETS TOKYO, Feb. 16, 2021 /PRNewswire/ Today, the Philippine government in partnership with the Japan Hygiene Products Industry Association (JHPIA) organized an online briefing with JHPIA members to promote investment opportunities in the Philippines for manufacturers of PPE, hygiene products and medical supplies based in Japan. The webinar showcased the competitive advantage of the Philippines as a manufacturing base for companies not only from Japan but also from neighbouring markets such as Taiwan, South Korea and Malaysia.  Yokoisada mask manufacturing plant

Research Study Shows Functional Fluidics Biomarkers Can Help Predict Sickle Cell Disease Pain Crises and Monitor Drug Therapy Progress

Research Study Shows Functional Fluidics Biomarkers Can Help Predict Sickle Cell Disease Pain Crises and Monitor Drug Therapy Progress News provided by Share this article DETROIT, Feb. 16, 2021 /PRNewswire/ Functional Fluidics ( https://www.functionalfluidics.com/) recently participated in a pivotal study that indicates their biomarkers of red blood cell health can help define and predict acute pain crises in individuals with Sickle Cell Disease (SCD). This addresses a tremendous need for well-validated biomarkers to objectively monitor red blood cell health in individuals with sickle cell disease. Red Blood Cell Biomarker Assays developed by Functional Fluidics showed significant correlation with patient-reported events in the recently published American Society of Hematology Blood Magazine

MDVIP Expands In Michigan With Five Primary Care Physicians

MDVIP Expands In Michigan With Five Primary Care Physicians Drs. Susan Baker, Bruce M. Baker, Paul R. Ehrmann, A.J. Ronan, and Patricia J. Roy Open MDVIP-Affiliated Practices to Deliver Personalized, Preventive Medicine Across the Lower Peninsula News provided by Share this article Share this article BOCA RATON, Fla., Feb. 16, 2021 /PRNewswire/  MDVIP, the market leader in personalized healthcare with over 1,000 physicians nationwide, announced the opening of five new affiliated primary care practices in Michigan. Family medicine physicians Susan Baker, D.O. and Bruce M. Baker, D.O. (Grand Rapids), Paul R. Ehrmann, D.O. (Royal Oak/Detroit), A.J. Ronan, D.O. (Okemos/Lansing) and Patricia J. Roy, D.O. (Muskegon) have joined the MDVIP primary care network to deliver a better healthcare experience with an emphasis on wellness and prevention. With the addition of these five affiliates, MDVIP s network footprint has grown to over 30 primary care physicians in Michigan.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.